Review
Side effects of anti-TNF therapy: current knowledge
Affiliations
- PMID: 12463468
Item in Clipboard
Review
Side effects of anti-TNF therapy: current knowledge
Clin Exp Rheumatol.
2002 Nov-Dec.
Abstract
The development of the anti-TNF therapies is a milestone in the therapy of rheumatic diseases. As in all new treatment opportunities it is of concern whether all potential undesired side effects have been evaluated within the clinical trials which have lead to approval of the drugs. Postmarketing experience and pharmacovigilance programs are necessary to determine the overall safety profile of the new agents. From the clinical trials and the practical experience of the first years we know that side effects have occurred in patients treated with anti-TNF agents. Sufficient knowledge about these partly specific side effects is critical for rheumatologists who treat their patients with these very effective biologic drugs.
Similar articles
-
Safety of anakinra, a recombinant interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis and comparison to anti-TNF-alpha agents.Clin Exp Rheumatol. 2002 Sep-Oct;20(5 Suppl 27):S35-41. Clin Exp Rheumatol. 2002. PMID: 14989428 Review.
-
Problems encountered during anti-tumour necrosis factor therapy.Best Pract Res Clin Rheumatol. 2006 Aug;20(4):757-90. doi: 10.1016/j.berh.2006.06.002. Best Pract Res Clin Rheumatol. 2006. PMID: 16979537 Review.
-
The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.Int J Rheum Dis. 2009 Jul;12(2):118-24. doi: 10.1111/j.1756-185X.2009.01393.x. Int J Rheum Dis. 2009. PMID: 20374328
-
Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.JAMA. 2009 Feb 18;301(7):737-44. doi: 10.1001/jama.2009.146. JAMA. 2009. PMID: 19224750
-
[Safety of anti-TNFα biological drugs].Reumatismo. 2005;57(4 Suppl):34-9. doi: 10.4081/reumatismo.2005.4s.34. Reumatismo. 2005. PMID: 16385354 Review. Italian.
Cited by
-
Anti-TNF therapies: a comprehensive analysis of adverse effects associated with immunosuppression.Rheumatol Int. 2011 Mar;31(3):327-37. doi: 10.1007/s00296-009-1292-x. Epub 2009 Dec 16. Rheumatol Int. 2011. PMID: 20013267
-
Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study.Arthritis Res Ther. 2004;6(6):R535-43. doi: 10.1186/ar1440. Epub 2004 Sep 23. Arthritis Res Ther. 2004. PMID: 15535831 Free PMC article.
-
Electroacupuncture improves trinitrobenzene sulfonic Acid-induced colitis, evaluated by transcriptomic study.Evid Based Complement Alternat Med. 2014;2014:942196. doi: 10.1155/2014/942196. Epub 2014 Jun 9. Evid Based Complement Alternat Med. 2014. PMID: 24995035 Free PMC article.
-
Systematic review and meta-analysis on the association of tuberculosis in Crohn's disease patients treated with tumor necrosis factor-α inhibitors (Anti-TNFα).World J Gastroenterol. 2018 Jul 7;24(25):2764-2775. doi: 10.3748/wjg.v24.i25.2764. World J Gastroenterol. 2018. PMID: 29991880 Free PMC article.
-
Gene expression analysis of rheumatoid arthritis synovial lining regions by cDNA microarray combined with laser microdissection: up-regulation of inflammation-associated STAT1, IRF1, CXCL9, CXCL10, and CCL5.Scand J Rheumatol. 2012 May;41(3):170-9. doi: 10.3109/03009742.2011.623137. Epub 2012 Mar 9. Scand J Rheumatol. 2012. PMID: 22401175 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials